Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Microbot Medical Inc. Director's Dealing 2010

Mar 18, 2010

33819_dirs_2010-03-18_c1539c39-0ff9-4450-8f6d-aea77fad8e8a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STEMCELLS INC (STEM)
CIK: 0000883975
Period of Report: 2010-03-17

Reporting Person: Young Rodney KB (CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-03-17 Common Stock S 30000 $1.23 Disposed 301617 Direct

Footnotes

F1: The $1.23 per share price was the weighted average price of open market sales by Mr. Young on 3/17/2010. Actual prices ranged from $1.23 per share to $1.2307 per share. Mr. Young will provide full information about the number of shares sold at each price, upon request by the SEC, the issuer or any security holder of the issuer.

F2: Includes (1) 226,667 restricted stock units, with 1/4 of those vesting on each of the four anniversaries following the May 15, 2009 grant date and (2) 68,750 restricted stock units, vesting on March 10, 2011.